Table 3

TIDieR checklist results

StudiesNameWhyMaterialsProceduresWho providedHowWhereWhen and how muchTailoringModificationsHow well: Planned adherenceHow well: Actual adherence
No intervention or routine care controlled trials
Chen
201629
YesYesPartial*YesYesYesNoPartial†N/AN/AN/AN/A
Matsuoka
200630
YesYesPartial*YesPartial‡YesPartial§NoYesN/AN/AN/A
Nicoletti
201431
YesYesPartial¶NoPartial‡YesYesYesPartial**N/AN/AN/A
Nolte
200627
YesPartial††Partial*YesYesPartial‡‡Partial§Partial***N/AN/AN/AN/A
Richard
201832
YesYesPartial§§YesPartial‡Partial¶¶Partial§YesN/AN/AN/AN/A
Head-to-head trial
Beresniak
201728
YesYesPartial§§YesPartial‡NoNoYesPartial**N/AN/AN/A
Total6 Yes
0 Partial
0 No
0 n/A
5 Yes
1 Partial
0 No
0 n/A
0 Yes
6 Partial
0 No
0 n/A
5 Yes
0 Partial
1 No
0 n/A
2 Yes
4 Partial
0 No
0 n/A
3 Yes
2 Partial
1 No
0 n/A
1 Yes
3 Partial
2 No
0 n/A
3 Yes
2 Partial
1 No
0 n/A
1 Yes
2 Partial
0 No
3 n/A
0 Yes
0 Partial
0 No
6 n/A
0 Yes
0 Partial
0 No
6 n/A
0 Yes
0 Partial
0 No
6 n/A
  • Green indicates that it was reported consistent with TIDieR criteria; yellow indicates partially consistent reporting; red indicates not reported adequately.

  • *Information on how to access materials not provided.

  • †Duration of all sessions not provided.

  • ‡Training information not provided.

  • §Details about infrastructure and other relevant feature not provided.

  • ¶Specific products not described.

  • **Details regarding how adaptations were made not provided.

  • ††Details about rationale underlying intervention not provided.

  • ‡‡Unclear if entire sessions was individual format.

  • §§Specific brand information not provided.

  • ¶¶Number of participants per group/number of groups not specified.

  • ***Timeline of intervention provision unclear.

  • N/A, not applicable; TIDieR, Template for Intervention Description and Replication.